Organon Operating Cycle from 2010 to 2026

OGN Stock  USD 7.39  0.33  4.67%   
Organon Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 190.18. During the period from 2010 to 2026, Organon Operating Cycle quarterly data regression pattern had sample variance of  3,493 and median of  136.78. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
237.93
Current Value
190.18
Quarterly Volatility
59.10543354
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Depreciation And Amortization of 481.4 M, Interest Expense of 282.2 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0423 or PTB Ratio of 2.16. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
  
Build AI portfolio with Organon Stock
Check out the analysis of Organon Correlation against competitors.
Evaluating Organon's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Organon Co's fundamental strength.

Latest Organon's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Organon Co over the last few years. It is Organon's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organon's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Organon Operating Cycle Regression Statistics

Arithmetic Mean187.43
Geometric Mean179.13
Coefficient Of Variation31.53
Mean Deviation53.63
Median136.78
Standard Deviation59.11
Sample Variance3,493
Range162
R-Value0.79
Mean Square Error1,412
R-Squared0.62
Significance0.0002
Slope9.22
Total Sum of Squares55,895

Organon Operating Cycle History

2026 190.18
2025 237.93
2024 264.37
2023 299.07
2022 254.53
2021 227.75
2020 235.77

About Organon Financial Statements

Organon investors utilize fundamental indicators, such as Operating Cycle, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 237.93  190.18 

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving against Organon Stock

  0.3721P Aurora CannabisPairCorr
  0.32WEED Canopy Growth CorpPairCorr
  0.31KG Kestrel Group Symbol ChangePairCorr
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out the analysis of Organon Correlation against competitors.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.56)
Dividend Share
0.34
Earnings Share
0.72
Revenue Per Share
23.954
Quarterly Revenue Growth
(0.05)
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.